Načítá se...
Trial of Divalproex for Bipolar Disorder
The safety and effectiveness of divalproex sodium (Depakapote®) in the treatment of 40 children and adolescents, aged 7 to 19 years, with a primary diagnosis of bipolar disorder were evaluated by open-label study (2-8 weeks) at the University of Texas, Galveston; University of Pennsylvania, Philadel...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Pediatric Neurology Briefs Publishers
2002-10-01
|
| Edice: | Pediatric Neurology Briefs |
| Témata: | |
| On-line přístup: | https://www.pediatricneurologybriefs.com/articles/1570 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|